[1] Jirimutu, Wang Z, Ding GH, et al. Genome sequences of wild and domestic bactrian camels[J]. Nat Commun, 2012, 3(1): 1202. doi:  10.1038/ncomms2192
[2] Li HN, Mu YW, Yan JR, et al. Label-free photoelectrochemical immunosensor for neutrophil gelatinase-associated lipocalin based on the use of nanobodies[J]. Anal Chem, 2015, 87(3): 2007–2015. doi:  10.1021/ac504589d
[3] Steeland S, Vandenbroucke RE, Libert C. Nanobodies as therapeutics: big opportunities for small antibodies[J]. Drug Discovery Today, 2016, 21(7): 1076–1113. doi:  10.1016/j.drudis.2016.04.003
[4] Manglik A, Kobilka BK, Steyaert J. Nanobodies to study G protein-coupled receptor structure and function[J]. Ann Rev Pharmacol Toxicol, 2017, 57: 19–37. doi:  10.1146/annurev-pharmtox-010716-104710
[5] Chakravarty R, Goel S, Cai WB. Nanobody: the "magic bullet" for molecular imaging?[J]. Theranostics, 2014, 4(4): 386–398. doi:  10.7150/thno.8006
[6] Chung CP, Nisengard RJ, Slots J, et al. Bacterial IgG and IgM antibody titers in acute necrotizing ulcerative gingivitis[J]. J Periodontol, 1983, 54(9): 557–562. doi:  10.1902/jop.1983.54.9.557
[7] Hornbeck P. Enzyme‐linked immunosorbent assays[J]. Curr Protoc Immunol, 1992, 1(1): 2.1.1–2.1.22. doi:  10.1002/0471142735.im0201s01
[8] Cohen MC, Cohen S. Cytokine function: a study in biologic diversity[J]. Am J Clin Pathol, 1996, 105(5): 589–598. doi:  10.1093/ajcp/105.5.589
[9] Overbergh L, Valckx D, Waer M, et al. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR[J]. Cytokine, 1999, 11(4): 305–312. doi:  10.1006/cyto.1998.0426
[10] Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes[J]. Nature, 1996, 383(6603): 787–793. doi:  10.1038/383787a0
[11] Pravetoni M, Laudenbach M, Baruffaldi F, et al. Cytokine-mediated germinal center reprogramming enhances vaccine efficacy[J]. J Immunol, 2017, 198(S1): 147.19.
[12] McInnes IB, Buckley CD, Isaacs JD. Cytokines in rheumatoid arthritis—shaping the immunological landscape[J]. Nat Rev Rheumatol, 2016, 12(1): 63–68. doi:  10.1038/nrrheum.2015.171
[13] Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system[J]. Nat Immunol, 2015, 16(4): 343–353. doi:  10.1038/ni.3123
[14] Torok KS, Kurzinski K, Kelsey C, et al. Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles[J]. Semin Arthritis Rheu, 2015, 45(3): 284–293. doi:  10.1016/j.semarthrit.2015.06.006
[15] Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more[J]. Immunol Today, 1996, 17(3): 138–146. doi:  10.1016/0167-5699(96)80606-2
[16] Wynn TA. Type 2 cytokines: mechanisms and therapeutic strategies[J]. Nat Rev Immunol, 2015, 15(5): 271–282. doi:  10.1038/nri3831
[17] Raphael I, Nalawade S, Eagar TN, et al. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases[J]. Cytokine, 2015, 74(1): 5–17. doi:  10.1016/j.cyto.2014.09.011
[18] Yang B, Zhou XC, Lan C. Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome[J]. BMC Gastroenterol, 2015, 15(1): 43. doi:  10.1186/s12876-015-0272-8
[19] Zhang WJ, Jang S, Jonsson CB, et al. Models of cytokine dynamics in the inflammatory response of viral zoonotic infectious diseases[J]. Math Med Biol: A J IMA, 2019, 36(3): 269–295. doi:  10.1093/imammb/dqy009
[20] El-Boshy M, Abbas H, El-Khodery S, et al. Cytokine response and clinicopathological findings in Brucella infected camels (Camelus dromedarius)[J]. Vet Med, 2009, 54(1): 25–32. doi:  10.17221/3044-VETMED
[21] Allam TS, Saleh NS, Abo-Elnaga TR, et al. Cytokine response and immunological studies in Camels (Camelus Dromedarius) with respiratory diseases at Matrouh Province[J]. Alexandria J Vet Sci, 2017, 53(1): 116–124. doi:  10.5455/ajvs.259788
[22] Odbileg R, Lee S-I, Ohashi K, et al. Cloning and sequence analysis of llama (lama glama): Th2(IL-4, IL-10 and IL-13) cytokines[J]. Vet Immunol Immunopathol, 2005, 104(3-4): 145–153. doi:  10.1016/j.vetimm.2004.11.002
[23] Odbileg R, Purevtseren B, Gantsetseg D, et al. Cytokine responses in camels (Camelus bactrianus) vaccinated with Brucella abortus strain 19 vaccine[J]. J Vet Med Sci, 2008, 70(2): 197–201. doi:  10.1292/jvms.70.197
[24] Arias N, Velapatiño B, Hung A, et al. Cytokines expression in alpacas and llamas exposed to cold stress[J]. Small Ruminant Res, 2016, 141: 135–140. doi:  10.1016/j.smallrumres.2016.07.016
[25] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2?ΔΔCT method[J]. Methods, 2001, 25(4): 402–408. doi:  10.1006/meth.2001.1262
[26] Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR[J]. Nucleic Acids Res, 2001, 29(9): e45. doi:  10.1093/nar/29.9.e45
[27] Schmitt N, Ueno H. Regulation of human helper T cell subset differentiation by cytokines[J]. Curr Opin Immunol, 2015, 34: 130–136. doi:  10.1016/j.coi.2015.03.007
[28] Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice[J]. Cardiovasc Res, 2008, 79(3): 360–376. doi:  10.1093/cvr/cvn120
[29] Armitage RJ, Macduff BM, Spriggs MK, et al. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines[J]. J Immunol, 1993, 150(9): 3671–3680.
[30] Farooq F, Beck K, Paolino KM, et al. Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine[J]. Sci Rep, 2016, 6(1): 27944. doi:  10.1038/srep27944
[31] Reinherz EL, Schlossman SF. The differentiation and function of human T lymphocytes[J]. Cell, 1980, 19(4): 821–827. doi:  10.1016/0092-8674(80)90072-0
[32] Powrie F, Menon S, Coffman RL. Interleukin‐4 and interleukin‐10 synergize to inhibit cell‐mediated immunity in vivo[J]. Eur J Immunol, 1993, 23(9): 2223–2229. doi:  10.1002/eji.1830230926
[33] Mosser DM, Zhang X. Interleukin‐10: new perspectives on an old cytokine[J]. Immunol Rev, 2008, 226: 205–218. doi:  10.1111/j.1600-065X.2008.00706.x
[34] Sahoo A, Wali S, Nurieva R. T helper 2 and T follicular helper cells: regulation and function of interleukin-4[J]. Cytokine Growth Factor Rev, 2016, 30: 29–37. doi:  10.1016/j.cytogfr.2016.03.011
[35] Rousset F, Garcia E, Defrance T, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes[J]. Proc Natl Acad Sci USA, 1992, 89(5): 1890–1893. doi:  10.1073/pnas.89.5.1890
[36] Ng TH, Britton GJ, Hill EV, et al. Regulation of adaptive immunity; the role of interleukin-10[J]. Front Immunol, 2013, 4: 129.
[37] Minty A, Chalon P, Derocq JM, et al. lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responses[J]. Nature, 1993, 362(6417): 248–250. doi:  10.1038/362248a0
[38] Shepard HH, Green RD, Hennig RL, et al. Validation and repeatability of measurement of antibody response to ovalbumin in beef cattle[J]. Texas J Agric Nat Resour, 1993, 6: 81–86.
[39] Tomašić J, Hanzl-Dujmović I, Špoljar B, et al. Comparative study of the effects of peptidoglycan monomer and structurally related adamantyltripeptides on humoral immune response to ovalbumin in the mouse[J]. Vaccine, 2000, 18(13): 1236–1243. doi:  10.1016/S0264-410X(99)00382-5
[40] Kasashima S, Kawashima A, Zen Y, et al. Upregulated interleukins (IL-6, IL-10, and IL-13) in immunoglobulin G4-related aortic aneurysm patients[J]. J Vasc Surg, 2018, 67(4): 1248–1262. doi:  10.1016/j.jvs.2016.12.140
[41] Ma LL, Liang Y, Fang MY, et al. The cytokines (IFN-γ, IL-2, IL-4, IL-10, IL-17) and Treg cytokine (TGF-β1) levels in adults with immune thrombocytopenia[J]. Die Pharm-An Int J Pharm Sci, 2014, 69(9): 694–697.
[42] Ahn H, Kwon HM, Lee E, et al. Role of inflammasome regulation on immune modulators[J]. J Biomed Res, 2018, 32(6): 401–410. doi:  10.7555/JBR.32.20170120
[43] Webb ES, Liu P, Baleeiro R, et al. Immune checkpoint inhibitors in cancer therapy[J]. J Biomed Res, 2018, 32(5): 317–326.